ProfileGDS4718 / 223921_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 89% 87% 76% 88% 86% 77% 78% 87% 87% 87% 88% 86% 81% 78% 77% 83% 87% 77% 79% 78% 87% 87% 89% 90% 85% 79% 87% 74% 90% 78% 78% 77% 85% 90% 79% 78% 78% 83% 87% 73% 90% 76% 74% 78% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.0633789
GSM549102patient 115, normal, homogenized [OPG study]8.672887
GSM549104patient 119, normal, homogenized [OPG study]7.5019376
GSM549108patient 138, normal, homogenized [OPG study]8.8342188
GSM549119patient 077, normal, homogenized [OPG study]8.5832686
GSM549133patient 032, cancer, homogenized [OPG study]7.6655477
GSM549139patient 042, cancer, homogenized [OPG study]7.7131478
GSM549099patient 107, normal, homogenized [OPG study]8.6066887
GSM549109patient 139, normal, homogenized [OPG study]8.696887
GSM549110patient 046, normal, homogenized [OPG study]8.8072687
GSM549114patient 063, normal, homogenized [OPG study]9.093788
GSM549122patient 082, normal, homogenized [OPG study]8.6408586
GSM549134patient 033, cancer, homogenized [OPG study]8.0233981
GSM549136patient 036, cancer, homogenized [OPG study]7.7121278
GSM549140patient 044, cancer, homogenized [OPG study]7.6239677
GSM549111patient 047, normal, homogenized [OPG study]8.2789383
GSM549113patient 057, normal, homogenized [OPG study]8.8471787
GSM549132patient 031, cancer, homogenized [OPG study]7.582477
GSM549137patient 038, cancer, homogenized [OPG study]7.7328179
GSM549142patient 047, cancer, homogenized [OPG study]7.4303478
GSM549100patient 110, normal, homogenized [OPG study]8.7619587
GSM549107patient 135, normal, homogenized [OPG study]8.7729787
GSM549115patient 068, normal, homogenized [OPG study]9.3035589
GSM549116patient 072, normal, homogenized [OPG study]9.3074890
GSM549120patient 078, normal, homogenized [OPG study]8.4544685
GSM549131patient 030, cancer, homogenized [OPG study]7.8875279
GSM549118patient 074, normal, homogenized [OPG study]8.844987
GSM549129patient 027, cancer, homogenized [OPG study]7.3417774
GSM549123patient 088, normal, homogenized [OPG study]9.177590
GSM549124patient 006, cancer, homogenized [OPG study]7.5897278
GSM549126patient 015, cancer, homogenized [OPG study]7.6162378
GSM549128patient 025, cancer, homogenized [OPG study]7.6454977
GSM549103patient 117, normal, homogenized [OPG study]8.3279285
GSM549117patient 073, normal, homogenized [OPG study]9.4359390
GSM549138patient 041, cancer, homogenized [OPG study]7.7717279
GSM549141patient 045, cancer, homogenized [OPG study]7.7683778
GSM549130patient 028, cancer, homogenized [OPG study]7.6407378
GSM549101patient 111, normal, homogenized [OPG study]8.1916883
GSM549105patient 128, normal, homogenized [OPG study]8.75387
GSM549106patient 134, normal, homogenized [OPG study]7.292173
GSM549112patient 048, normal, homogenized [OPG study]9.2168290
GSM549125patient 011, cancer, homogenized [OPG study]7.349176
GSM549127patient 024, cancer, homogenized [OPG study]7.3282674
GSM549135patient 035, cancer, homogenized [OPG study]7.7862678